Supplemental Reading

Carmeliet E and Mubagwa K. Antiarrhythmic drugs and cardiac ion channels: mechanisms of action. Prog Biophys Molec Biol 1998;70:1-72.

Cavero I et al. Drugs that prolong QT interval as an unwanted effect: Assessing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opinion Pharmacotherapy 2000;1:947-973.

Hohnloser SH. Proarrhythmia with class III antiarrhythmic drugs: Types, risks, and management. Am J Cardiol 1997;80(8A):82G-89G.

Huikuri HV, Castellanos A, and Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-1482.

Link MS et al. Antiarrhythmic drug therapy for ventricular arrhythmias: Current perspectives. J Cardiovasc Electrophys 1996;7:653-670.

Nattel S and Singh BN. Evolution, mechanisms, and classification of antiarrhythmic drugs: Focus on class III actions. Am J Cardiol 1999;84(9A):11R-19R.

Reiffel JA. Drug choices in the treatment of atrial fibrillation. Am J Cardiol 2000;85(10A):12D-19D.

Roden DM and George AL Jr. The cardiac ion channels: Relevance to management of arrhythmias. Annu Rev Med 1996;47:135-148.

Singh BN and Sarma JS. What niche will newer class III antiarrhythmic drugs occupy? Curr Cardiol Rep 2001;3(4):314-323.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook

Post a comment